• Guideline Summary
  • NGC:010791
  • 2015 Aug

Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism.

  • Guideline Summary
  • NGC:010622
  • 2014 Dec

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.

  • Guideline Summary
  • NGC:010171
  • 1995 (revised 2013)

ACR Appropriateness Criteria® suspected lower-extremity deep vein thrombosis.

  • Guideline Summary
  • NGC:010951
  • 2016 Feb

Antithrombotic therapy for VTE disease: CHEST guideline and Expert Panel report.

  • Guideline Summary
  • NGC:009949
  • 2013 Jun

Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism.

  • Guideline Summary
  • NGC:005947
  • 2000 Oct (revised 2007 Aug; reaffirmed 2012)

Prevention of deep vein thrombosis and pulmonary embolism.

  • Guideline Summary
  • NGC:010742
  • 2005 Jun (revised 2015 Jun 23)

Suspected cancer: recognition and referral.

  • Guideline Summary
  • NGC:009844
  • 2007 Dec (revised 2013 Jun; reaffirmed 2015 Feb)

Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

  • Guideline Summary
  • NGC:010374
  • 2013 May

Follow-up care for early-stage breast cancer.

  • Guideline Summary
  • NGC:010617
  • 2008 May (revised 2014 Nov)

Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (including review of TA 142).

  • Guideline Summary
  • NGC:010668
  • 1995 (revised 2014)

ACR Appropriateness Criteria® upper extremity swelling.